Together, we present a resource for the lipid droplet and neurodegenerative disease communities, offering new insight into how the most impactful genetic modifier of AD risk, APOE, can alter the composition and dynamics of an organelle increasingly implicated in brain health and disease. This evidence concerns the gene APOE and Alzheimer disease.